Impact of eplerenone on cardiovascular outcomes in heart failure patients with hypokalaemia
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of eplerenone on cardiovascular outcomes in heart failure patients with hypokalaemia
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF HEART FAILURE
Volume 19, Issue 6, Pages 792-799
Publisher
Wiley
Online
2016-11-21
DOI
10.1002/ejhf.688
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Incidence, Predictors, and Outcomes Related to Hypo- and Hyperkalemia in Patients With Severe Heart Failure Treated With a Mineralocorticoid Receptor Antagonist
- (2014) Orly Vardeny et al. Circulation-Heart Failure
- Incident hyperkalemia may be an independent therapeutic target in low ejection fraction heart failure patients: Insights from the HEAAL study
- (2014) P. Rossignol et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Time to retrieve the best benefits from renin angiotensin aldosterone system (RAAS) inhibition in heart failure patients with reduced ejection fraction: Lessons from randomized controlled trials and registries
- (2014) Patrick Rossignol et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Incidence, Determinants, and Prognostic Significance of Hyperkalemia and Worsening Renal Function in Patients With Heart Failure Receiving the Mineralocorticoid Receptor Antagonist Eplerenone or Placebo in Addition to Optimal Medical Therapy
- (2013) Patrick Rossignol et al. Circulation-Heart Failure
- Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis
- (2013) K. Damman et al. EUROPEAN HEART JOURNAL
- Safety and Efficacy of Eplerenone in Patients at High Risk for Hyperkalemia and/or Worsening Renal Function
- (2013) Romain Eschalier et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Subcutaneous adipose tissue in relation to subclinical atherosclerosis and cardiometabolic risk factors in midlife women
- (2011) Rachel P Wildman et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- The meaning of hypokalemia in heart failure
- (2011) Agata Bielecka-Dabrowa et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Eplerenone Survival Benefits in Heart Failure Patients Post-Myocardial Infarction Are Independent From its Diuretic and Potassium-Sparing Effects
- (2011) Patrick Rossignol et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Postoperative atrial fibrillation predicts long-term survival after aortic-valve surgery but not after mitral-valve surgery: a retrospective study
- (2011) N. Girerd et al. BMJ Open
- Hypokalemia and Outcomes in Patients With Chronic Heart Failure and Chronic Kidney Disease
- (2010) C. Barrett Bowling et al. Circulation-Heart Failure
- Rationale and design of the Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure (EMPHASIS-HF)
- (2010) Faiez Zannad et al. EUROPEAN JOURNAL OF HEART FAILURE
- Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
- (2010) Faiez Zannad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Graded activity for workers with low back pain: Who benefits most and how does it work?
- (2008) J. Bart Staal et al. ARTHRITIS AND RHEUMATISM
- A propensity-matched study of low serum potassium and mortality in older adults with chronic heart failure
- (2008) A. Brent Alper et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- EGFR Mutations Predict Survival Benefit From Gefitinib in Patients With Advanced Lung Adenocarcinoma: A Historical Comparison of Patients Treated Before and After Gefitinib Approval in Japan
- (2008) Toshimi Takano et al. JOURNAL OF CLINICAL ONCOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started